US Patent 9187453 Heterocyclic compound
Patent 9187453 was granted and assigned to Takeda Pharmaceutical Company on November, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+330 characters)
Article
Patent abstract
The present invention provides an agent for the prophylaxis or treatment of autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus etc.) and the like, which has a superior Tyk2 inhibitory action.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09187453 Heterocyclic compound US Patent 9187453 Heterocyclic compound
Infobox
Patent Number
09187453
Patent Number
9187453
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09187453 Heterocyclic compound
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09187453
Date of patent
November 17, 2015
Patent application number
14388452
Date Filed
March 27, 2013
Patent primary examiner
Find more entities like US Patent 9187453 Heterocyclic compound
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
